Reports
Global Peripheral Artery Disease Market Share, Growth, Size, Outlook, Report: By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Others; By Treatment; By Distribution Channel; By End User; Regional Analysis; Supplier Landscape; 2023-2031
Global Peripheral Artery Disease Market Outlook
The global peripheral artery disease market size attained a value of USD 4.42 billion in 2022, driven by increasing geriatric population, unhealthy lifestyles led by the adults, increasing prevalence of obesity, diabetes, and high blood pressure, among others. The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2023-2031 to attain a value of USD 7.66 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
According to the peripheral artery disease market report, peripheral artery disease or PAD is widely prevalent and is considered as a disease which is a large contributor towards the growing burden of cardiovascular diseases. The peripheral artery disease market overview suggests that the technological advancements in endovascular and surgical treatments of peripheral artery disease are fuelling the market growth. In the coming years, the peripheral arterial disease market is also projected to witness growth, driven by the increasing prevalence of atherosclerosis. Increasing awareness regarding peripheral artery disease is resulting in more patients seeking diagnostics and treatment at an earlier stage, promoting better outcomes.
The Asia Pacific to Grow at a Steady Pace During the Forecast Period with the Growing Population
According to the peripheral artery disease market research, Asia Pacific is expected to have a significant market share in the forecast period. There are a variety of factors driving the growth of peripheral artery disease market in the Asia Pacific region. One of the key factors is the large population with unmet medical conditions such as obesity, diabetes, and high blood pressure, which might propel the risk of peripheral artery disease. In addition, the healthcare infrastructure in the region has been growing significantly along with the GDP, which is expected to enlarge the peripheral artery disease market size in the forecast period. Moreover, there have been some notable developments amongst the leading players in the market, leading to increased competition globally and expanded growth of the global peripheral artery disease market size. Meanwhile, in North America, prevalent lifestyle issues such as obesity and lack of intake of proper diet in strong economies such as the United States are expanding the peripheral artery disease US market size.
Peripheral Artery Disease: Market Segmentation
Peripheral artery disease is a medical term that refers to the narrowing of arteries in human body that reduces the flow of blood in the lower body including legs. As a result, the oxygen and blood levels in the lower body reach below the required level, consequently leading to pain in walking. Peripheral artery disease can also be a sign of blocking or clogging of the arteries. This can usually be treated by lifestyle modification, regular exercise, and quitting tobacco in any form.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The peripheral artery disease market segmentation based on type is:
- Peripheral Angioplasty Balloons
- Breakup by Type
- Old/Normal Balloons
- Cutting and Scoring Balloons
- Drug-Coated Balloons
- Peripheral Stents
- Breakup by Type
- Self-Expandable
- Balloon-Expandable
- Covered Stents
- Drug-Eluting Stents
- Peripheral Catheters
- Breakup by Type
- Angiography Catheters
- Guiding Catheters
- Inferior Vena Cava (IVC) Filters
- Breakup by Type
- Permanent Filters
- Retrievable Filters
- Plaque Modification Devices
- Breakup by Type
- Thrombectomy Devices
- Atherectomy Devices
- Haemodynamic Flow Alteration Devices
- Breakup by Type
- Embolic Protection Devices
- Chronic Total Occlusion Devices
- Peripheral Accessories
- Breakup by Type
- Peripheral Vascular Closure Devices
- Introducer Sheaths
- Guidewires
- Balloon Inflation Devices
- Others
- Breakup by Type
The EMR report looks into the regional markets of peripheral artery disease like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Non-Invasive Procedures, coupled with Unhealthy Lifestyles to Propel the Demand for Peripheral Artery Disease Treatment
As per the peripheral artery disease market analysis, evolving health infrastructure has increased the usage of interventional devices like drug-eluting agents, atherectomy devices, and others, which is aiding the diagnostics infrastructure, leading to a heightened growth of peripheral arterial disease diagnostics market. Atherectomy is used to remove the plaque in arteries with the help of catheter and its demand in treating peripheral artery diseases (PADs) has increased majorly. Further, the demand for non-invasive or minimally-invasive endovascular procedures has increased recently because they offer shorter recovery time and minimal chances of post-surgery complications. This factor is further likely to boost the peripheral artery disease market share in the global healthcare industry. Moreover, the unhealthy lifestyle led by people worldwide, coupled with increased consumption of alcohols, tobacco, and smoking is anticipated to spike the number of cardiac arrests, blood clotting, and other heart conditions in the coming years, thereby boosting the demand for peripheral artery disease drugs, leading to an enlargement of the peripheral artery disease drugs market size.
The surge in geriatric population at a global level is likely to boost the susceptibility to peripheral artery diseases in the future. In this regard, initiatives taken to aid the health of geriatrics and favourable reimbursement policies of the government are the critical peripheral artery disease market trends. There is a clear correlation between ageing and occurrence of medical conditions such as diabetes, blood pressure, and heart related diseases, among others. This factor is likely to add to the peripheral artery disease market value in the forecast period. In addition, there have been mergers and acquisitions among the leading market players, which are expected to be the crucial driving factors propelling the growth of peripheral artery disease global market.
Key Industry Players in the Global Peripheral Artery Disease Market
The report presents a detailed analysis of the following key players in the global peripheral artery disease market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- AngioDynamics Inc.
- B. Braun Melsungen AG
- Biotronik Inc.
- Boston Scientific Corp.
- Cook Group Incorporated
- Terumo Corporation
- Koninklijke Philips N.V.
- Becton, Dickinson and Company
- W. L. Gore & Associates, Inc.
- LeMaitre Vascular, Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Treatment |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Peripheral Artery Disease Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Peripheral Artery Disease Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Peripheral Artery Disease Epidemiology (2016-2031)
5.3 Europe Peripheral Artery Disease Epidemiology (2016-2031)
5.4 Asia-Pacific Peripheral Artery Disease Epidemiology (2016-2031)
5.5 Latin America Peripheral Artery Disease Epidemiology (2016-2031)
5.6 Middle East & Africa Peripheral Artery Disease Epidemiology (2016-2031)
6 Global Peripheral Artery Disease Market Overview
6.1 Global Peripheral Artery Disease Market Historical Value (2016-2022)
6.2 Global Peripheral Artery Disease Market Forecast Value (2023-2031)
7 Global Peripheral Artery Disease Market Landscape
7.1 Peripheral Artery Disease: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Peripheral Artery Disease: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Treatment
7.2.3 Analysis by Distribution Channel
7.2.4 Analysis by End User
8 Peripheral Artery Disease Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Peripheral Artery Disease Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Peripheral Artery Disease Market Segmentation
11.1 Global Peripheral Artery Disease Market by Type
11.1.1 Market Overview
11.1.2 Peripheral Angioplasty Balloons
11.1.2.1 Old/Normal Balloons
11.1.2.2 Cutting and Scoring Balloons
11.1.2.3 Drug-Coated Balloons
11.1.3 Peripheral Stents
11.1.3.1 Self-Expandable
11.1.3.2 Balloon-Expandable
11.1.3.3 Covered Stents
11.1.3.4 Drug-Eluting Stents
11.1.4 Peripheral Catheters
11.1.4.1 Angiography Catheters
11.1.4.2 Guiding Catheters
11.1.5 Inferior Vena Cava (IVC) Filters
11.1.5.1 Permanent Filters
11.1.5.2 Retrievable Filters
11.1.6 Plaque Modification Devices
11.1.6.1 Thrombectomy Devices
11.1.6.2 Atherectomy Devices
11.1.7 Haemodynamic Flow Alteration Devices
11.1.7.1 Embolic Protection Devices
11.1.7.2 Chronic Total Occlusion Devices
11.1.8 Peripheral Accessories
11.1.8.1 Peripheral Vascular Closure Devices
11.1.8.2 Introducer Sheaths
11.1.8.3 Guidewires
11.1.8.4 Balloon Inflation Devices
11.2 Global Peripheral Artery Disease Market by Treatment
11.2.1 Market Overview
11.2.2 Oral
11.2.3 Parenteral
11.2.4 Others
11.3 Global Peripheral Artery Disease Market by Distribution Channel
11.3.1 Market Overview
11.3.2 Hospital Pharmacy
11.3.3 Retail Pharmacy
11.3.4 Others
11.4 Global Peripheral Artery Disease Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Others
11.5 Global Peripheral Artery Disease Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Peripheral Artery Disease Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Peripheral Artery Disease Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Peripheral Artery Disease Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Peripheral Artery Disease Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Peripheral Artery Disease Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 AngioDynamics Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 B. Braun Melsungen AG
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Biotronik Inc.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Boston Scientific Corp.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Cook Group Incorporated
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Terumo Corporation
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Koninklijke Philips N.V.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Becton, Dickinson and Company
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 W. L. Gore & Associates, Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 LeMaitre Vascular, Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Peripheral Artery Disease - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2022, the global market peripheral artery disease attained a value of USD 4.42 billion.
The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2023-2031 to reach a value of USD 7.66 billion by 2031.
The major drivers of the market include the increasing geriatric population, unhealthy lifestyles led by the adults, increasing prevalence of obesity, diabetes, and high blood pressure, among others.
The rising healthcare expenditure and the growing demand for minimally-invasive procedures to treat peripheral artery disease are expected to be the key trends guiding the growth of the industry.
What are the major regional markets of peripheral artery disease, according to the EMR report?
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, haemodynamic flow alteration devices, and peripheral accessories, among others are the major types based on which the market has been segmented.
The major players in the peripheral artery disease market are AngioDynamics Inc., B. Braun Melsungen AG, Biotronik Inc., Boston Scientific Corp., Cook Group Incorporated, Terumo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company., W. L. Gore & Associates, Inc., and LeMaitre Vascular, Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER